why choose us

First received: July 19, 2024

Clinical Trial: Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Human Immunodeficiency Virus

Study Type: INTERVENTIONAL


Official Title: Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment Among Women Living With HIV in Kenya

Brief Summary: The objective of this randomized, placebo-controlled trial is to evaluate whether intravaginal artesunate pessaries (vaginal inserts) can be used as adjuvant therapy following thermal ablation to improve Human papillomavirus (HPV) treatment outcomes in Women Living with Human Immunodeficiency Virus (WLWH).The study will evaluate whether women who use artesunate will have higher HPV clearance at 6 months, compared to those who used a placebo.The study will also assess the safety, adherence, and acceptability of…

Read more